Patents by Inventor Camella Bailey

Camella Bailey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6913907
    Abstract: The present invention relates to novel genes from E. faecalis and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of E. faecalis polypeptide activity. The invention additionally relates to diagnostic methods for detecting Enterococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Enterococcus.
    Type: Grant
    Filed: July 29, 2002
    Date of Patent: July 5, 2005
    Assignee: Human Genome Sciences, Inc.
    Inventors: Gil H. Choi, Camella Bailey, Alex Hromockyj, Charles A. Kunsch
  • Publication number: 20050043528
    Abstract: The present invention relates to novel genes from E. faecalis and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of E. faecalis polypeptide activity. The invention additionally relates to diagnostic methods for detecting Enterococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Enterococcus.
    Type: Application
    Filed: August 6, 2004
    Publication date: February 24, 2005
    Applicant: Human Genome Sciences, Inc.
    Inventors: Gil Choi, Camella Bailey, Alex Hromockyj, Charles Kunsch
  • Publication number: 20040265962
    Abstract: The present invention relates to novel genes from S. aureus and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of S. aureus polypeptide activity. The invention additionally relates to diagnostic methods for detecting Staphylococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Staphylococcus.
    Type: Application
    Filed: April 14, 2004
    Publication date: December 30, 2004
    Applicant: Human Genome Sciences, Inc.
    Inventors: Camella Bailey, Gil H. Choi
  • Patent number: 6753149
    Abstract: The present invention relates to novel genes from S. aureus and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of S. aureus polypeptide activity. The invention additionally relates to diagnostic methods for detecting Staphylococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Staphylococcus.
    Type: Grant
    Filed: May 6, 2002
    Date of Patent: June 22, 2004
    Assignee: Human Genome Sciences, Inc.
    Inventors: Camella Bailey, Gil H. Choi
  • Publication number: 20030186364
    Abstract: The present invention relates to novel genes from S. aureus and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of S. aureus polypeptide activity. The invention additionally relates to diagnostic methods for detecting Staphylococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Staphylococcus.
    Type: Application
    Filed: May 6, 2002
    Publication date: October 2, 2003
    Applicant: Human Genome Sciences, Inc.
    Inventors: Camella Bailey, Gil H. Choi
  • Publication number: 20030017495
    Abstract: The present invention relates to novel genes from E. faecalis and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of E. faecalis polypeptide activity. The invention additionally relates to diagnostic methods for detecting Enterococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Enterococcus.
    Type: Application
    Filed: July 29, 2002
    Publication date: January 23, 2003
    Applicant: Human Genome Sciences, Inc.
    Inventors: Gil H. Choi, Camella Bailey, Alex Hromockyj, Charles A. Kunsch
  • Patent number: 6448043
    Abstract: The present invention relates to a novel gene from E. faecalis, EF040, and the encoded polypeptides. Also provided are vectors, host cells, antibodies and methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of E. faecalis EF040 polypeptide activity. The invention additionally relates to diagnostic methods for detecting Enterococcus EF040 nucleic acids, encoded polypeptides and anti-EF040 antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Enterococcus.
    Type: Grant
    Filed: May 4, 1998
    Date of Patent: September 10, 2002
    Assignee: Human Genome Sciences, Inc.
    Inventors: Gil H. Choi, Camella Bailey, Alex Hromockyj, Charles A. Kunsch
  • Patent number: 6403337
    Abstract: The present invention relates to novel genes from S. aureus and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of S. aureus polypeptide activity. The invention additionally relates to diagnostic methods for detecting Staphylococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Staphylococcus.
    Type: Grant
    Filed: February 24, 2000
    Date of Patent: June 11, 2002
    Assignee: Human Genome Sciences, Inc.
    Inventors: Camella Bailey, Gil H. Choi
  • Publication number: 20020045737
    Abstract: The present invention relates to novel genes from E. faecalis and the polypeptides they encode. Also provided as are vectors, host cells, antibodies and methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of E. faecalis polypeptide activity. The invention additionally relates to diagnostic methods for detecting Enterococcus nucleic acids, polypeptides and antibodies in a biological sample. The present invention further relates to novel vaccines for the prevention or attenuation of infection by Enterococcus.
    Type: Application
    Filed: May 4, 1998
    Publication date: April 18, 2002
    Applicant: HUMAN GENOME SCIENCES, INC.
    Inventors: GIL H. CHOI, CAMELLA BAILEY, ALEX HROMOCKYJ, CHARLES A. KUNSCH